With the first round of CMS price negotiations behind us, and the next list of targets to be released in February 2026, it’s clear that theorized implications from the Inflation Reduction Act are becoming realities for the life sciences industry. In this episode, Jen and Mindy are joined by Putnam Associates Partner, Scott Briggs, to explore how companies can navigate the new pricing pressures and negotiation frameworks while continuing to innovate and ensure patient access to critical therapies.
For more information about Putnam’s work in Value, Pricing and Access, visit their website: https://www.putassoc.com/our-expertise/value-pricing-access/
For more information about Vynamic’s work in Market Access, visit: https://vynamic.com/what-we-do/health-industry/life-sciences/market-access/
Podcast Tags: healthcare, life sciences, product launch, market access, drug pricing, life sciences trends
Panel – Scott Briggs, Mindy McGrath, Jen Burke
Research & Production – Scott Briggs, Mindy McGrath, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
For the final installment in Vynamic’s 2025 health industry outlook series, Jen is joined by Vynamic’s Head of...
Listen nowHealth industry 2025: Navigating economic shifts, tech advances, new regulations, and innovations in Life Sciences, Health Services, & MedTech.
Read moreLife science organizations often encounter challenges with aligning strategy and execution during a product launch, leading to inefficiencies...
Read more